Funding Received
$74.6 Million in 3 Rounds from 6 Investors
Most Recent Funding
$50 Million Series B on April 22, 2014
Headquarters:
South San Francisco, CA
Description:
Principia Biopharma is focused on the R&D of differentiated small molecule drugs targeting inflammatory and autoimmune diseases, and cancer.
Founders:
Jack Taunton
Categories:
Biotechnology
Website:
http://www.principiabio.com

Company Details

Update

Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.

Current Team (8)

Update

Board Members and Advisors (6)

Update

Investors (6)

Update
  • B1ce9d2887c930e2d5d82b64a7eebcb9

    OrbiMed Advisors

    OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
  • D528595fec293143be89ec7d897eec3d

    Mission Bay Capital

    Mission Bay Capital, LLC, is an independent seed-stage venture firm focused on making pivotal,...
  • 29c01db5dd11b178b4bb308cec4bf8bd

    SR One

    Venture Capital
  • 99f428dd3112e8183cd21c4ed7cadca4

    New Leaf Venture Partners

    Health-Care Focused VC Firm
  • 138194732818d8ed6f01da9a359dfca9

    Morgenthaler Ventures

    Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
  • A72157320397be4c637c4da2b885a5f8

    Sofinnova Ventures

    Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...

Offices/Locations (1)

Update
  • Office

    400 East Jamie Court

    Suite 302

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • 725e0a4c8f61af8802dad41ac1cbdaae